32.jpg)
56.jpg)
USE OF BCL7A FOR THE DIAGNOSIS, PROGNOSIS, PREVENTION, IMPROVEMENT, RELIEF OR TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA, AND METHODS, KITS AND DEVICES BASED ON SAID USE
Patent number:
WO21260250
No items found.
Use of BCL7A for the diagnosis, prognosis, prevention, improvement, relief or treatment of diffuse large B-cell lymphoma, and methods, kits and devices based on said use. The present invention describes BCL7A for use in the diagnosis, prognosis, prevention, improvement, relief or treatment of diffuse large B-cell lymphoma, and methods, kits and devices based on said use.
Countries:
Spain
Regions:
Andalusia
Centers:
UNIVERSIDAD DE GRANADA, SERVICIO ANDALUZ DE SALUD
Other entities:
Sectors:
Health
Subsectors:
Biotechnology
TRL Level:
TRL 2 – technology concept formulated
BRL Level:
PDF Link:
Download hereVideo Link:
Watch it hereSustainable Development Goal:
Applications
- Less destruction of proximal healthy tissue. - Reduction of the possibility of resistance, recurrence and tumor metastasis. - Changes in the phenotype of CSCs and elimination of the CSC subpopulation of the tumor. - Useful for the treatment of tumors with greater depth.
Comments
Other related patents
Health
COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND OTHER DISEASES CAUSED BY RNA VIRUSES
Health
USE OF PLASMA-SYNTHESISED PYROL-DERIVED POLYMERS FOR THE NEUROPROTECTION AND RECONNECTION OF THE NERVOUS SYSTEM
Chemicals
Health
Food & Agro
Energy
Textile